Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-17

Clinical Trial Update: PREVAIL Paclitaxel-coated Balloon in Small Coronary Disease and High-bleeding Risk Patients

View source ↗

Summary

This Clinical Trial Update indicates the PREVAIL paclitaxel-coated balloon trial for small coronary disease in high-bleeding-risk patients is currently recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Paclitaxel-coated balloon (PREVAIL) (paclitaxel-coated balloon)

Snippet

Sponsor: Fundación EPIC | Conditions: Coronary Artery Disease | Status: RECRUITING